High-efficiency cellular reprogramming with microfluidics

Nature Methods

Volumn 13, Issue 5, 2016, Pages 446-452

  Luni, Camilla ^a,b   Giulitti, Stefano ^a,b   Serena, Elena ^a,b   Ferrari, Luca ^a,b   Zambon, Alessandro ^a,b   Gagliano, Onelia ^a,b   Giobbe, Giovanni G ^a,b   Michielin, Federica ^a,b   Knöbel, Sebastian ^c   Bosio, Andreas ^c   Elvassore, Nicola ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c MILTENYI BIOTEC GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MESSENGER RNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; LIVER CELL; MICROFLUIDICS; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOMATIC CELL; TRANSIENT EXPRESSION; CELL CULTURE; CELL REPROGRAMMING TECHNIQUE; CYTOLOGY; GENETICS; PROCEDURES;

CELLS, CULTURED; CELLULAR REPROGRAMMING; CELLULAR REPROGRAMMING TECHNIQUES; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICROFLUIDICS; RNA, MESSENGER;

EID: 84964344546     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.3832     Document Type: Article

References (38)

1. Boyer, L.A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).
2. Vallier, L., Alexander, M. & Pedersen, R.A. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci. 118, 4495-4509 (2005).
3. Vallier, L. et al. Activin/Nodal signaling maintains pluripotency by controlling Nanog expression. Development 136, 1339-1349 (2009).
4. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 131, 861-872 (2007).
5. Golipour, A. et al. A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network. Cell Stem Cell 11, 769-782 (2012).
6. Schlaeger, T.M. et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33, 58-63 (2015).
7. Giobbe, G.G. et al. Functional differentiation of human pluripotent stem cells on a chip. Nat. Methods 12, 637-640 (2015).
8. Giulitti, S., Magrofuoco, E., Prevedello, L. & Elvassore, N. Optimal periodic perfusion strategy for robust long-term microfuidic cell culture. Lab Chip 13, 4430-4441 (2013).
9. Takahashi, K. et al. Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm. Nat. Commun. 5, 3678 (2014).
10. Luni, C., Michielin, F., Barzon, L., Calabrò, V. & Elvassore, N. Stochastic model-assisted development of effcient low-dose viral transduction in microfuidics. Biophys. J. 104, 934-942 (2013).
11. Warren, L. et al. Highly effcient reprogramming to pluripotency and directed differentiation of human cells with synthetic modifed mRNA. Cell Stem Cell 7, 618-630 (2010).
12. Li, R. et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fbroblasts. Cell Stem Cell 7, 51-63 (2010).
13. Liu, X. et al. Sequential introduction of reprogramming factors reveals a time-sensitive requirement for individual factors and a sequential EMT-MET mechanism for optimal reprogramming. Nat. Cell Biol. 15, 829-838 (2013).
14. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
15. Zhou, T. et al. Generation of human induced pluripotent stem cells from urine samples. Nat. Protoc. 7, 2080-2089 (2012).
16. Xue, Y. et al. Generating a non-integrating human induced pluripotent stem cell bank from urine-derived cells. PLoS ONE 8, e70573 (2013).
17. Sharei, A. et al. A vector-free microfuidic platform for intracellular delivery. Proc. Natl. Acad. Sci. USA 110, 2082-2087 (2013).
18. Skelley, A.M., Kirak, O., Suh, H., Jaenisch, R. & Voldman, J. Microfuidic control of cell pairing and fusion. Nat. Methods 6, 147-152 (2009).
19. Anokye-Danso, F., Snitow, M. & Morrisey, E.E. How microRNAs facilitate reprogramming to pluripotency. J. Cell Sci. 125, 4179-4787 (2012).
20. Parchem, R.J. et al. Two miRNA clusters reveal alternative paths in late-stage reprogramming. Cell Stem Cell 14, 617-631 (2014).
21. Rais, Y. et al. Deterministic direct reprogramming of somatic cells to pluripotency. Nature 502, 65-70 (2013).
22. Gafni, O. et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 504, 282-286 (2013).
23. Vidal, S.E., Amlani, B., Chen, T., Tsirigos, A. & Stadtfeld, M. Combinatorial modulation of signaling pathways reveals cell-type-specifc requirements for highly effcient and synchronous iPSC reprogramming. Stem Cell Rep. 3, 574-584 (2014).
24. Bar-Nur, O. et al. Small molecules facilitate rapid and synchronous iPSC generation. Nat. Methods 11, 1170-1176 (2014).
25. Dimmeler, S., Ding, S., Rando, T.A. & Trounson, A. Translational strategies and challenges in regenerative medicine. Nat. Med. 20, 814-821 (2014).
26. Neuži, P., Giselbrecht, S., Länge, K., Huang, T.J. & Manz, A. Revisiting lab-on-a-chip technology for drug discovery. Nat. Rev. Drug Discov. 11, 620-632 (2012).
27. Luni, C., Serena, E. & Elvassore, N. Human-on-chip for therapy development and fundamental science. Curr. Opin. Biotechnol. 25, 45-50 (2014).
28. Zhou, T. et al. Generation of human induced pluripotent stem cells from urine samples. Nat. Protoc. 7, 2080-2089 (2012).
29. Unger, M.A., Chou, H.-P., Thorsen, T., Scherer, A. & Quake, S.R. Monolithic microfabricated valves and pumps by multilayer soft lithography. Science 288, 113-116 (2000).
30. Gómez-Sjöberg, R., Leyrat, A.A., Pirone, D.M., Chen, C.S. & Quake, S.R. Versatile, fully automated, microfuidic cell culture system. Anal. Chem. 79, 8557-8563 (2007).
31. Warren, L., Ni, Y., Wang, J. & Guo, X. Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci. Rep. 2, 657 (2012).
32. Singh, A. et al. Adhesion strength-based, label-free isolation of human pluripotent stem cells. Nat. Methods 10, 438-444 (2013).
33. Erban, R. & Chapman, S.J. Reactive boundary conditions for stochastic simulations of reaction-diffusion processes. Phys. Biol. 4, 16-28 (2007).
34. Moledina, F. et al. Predictive microfuidic control of regulatory ligand trajectories in individual pluripotent cells. Proc. Natl. Acad. Sci. USA 109, 3264-3269 (2012).
35. Kestin, J., Sokolov, M. & Wakeham, W.A. Viscosity of liquid water in the range-8 °C to 150 °C. J. Phys. Chem. Ref. Data 7, 941 (1978).
36. Russo, L., Berardi, V., Tardani, F., La Mesa, C. & Risuleo, G. Delivery of RNA and its intracellular translation into protein mediated by SDS-CTAB vesicles: potential use in nanobiotechnology. BioMed Res. Int. 2013, 734596 (2013).
37. Inui, M. et al. USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat. Cell Biol. 13, 1368-1375 (2011).
38. Johnson, W.E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127 (2007).